Thiazolidinediones and Cardiovascular Risk — A Question of Balance
نویسندگان
چکیده
منابع مشابه
Thiazolidinediones and Cardiovascular Risk — A Question of Balance
BACKGROUND Several recent meta-analyses of adverse event data from randomized controlled trials with rosiglitazone reveal a possible association between this thiazolidinedione and an increased risk of ischemic myocardial events. This has led to debate on the overall clinical benefit of glitazone therapy for type 2 diabetes. Pioglitazone, on the other hand, has the most extensive cardiovascular ...
متن کاملType 2 diabetes, thiazolidinediones, and cardiovascular risk.
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achieving adequate glycaemic control is an important aim of therapy. Thiazolidinediones, or glitazones, have been used for the treatment of diabetes for a decade. Rosiglitazone and pioglitazone are currently available, however recent concerns around cardiovascular safety have led to restrictions on their...
متن کاملPolycystic Ovarian Syndrome: Metformin or Thiazolidinediones for Cardiovascular Risk Reduction?
Address correspondence to Mary Moyer Janci, MSN, BC-ADM, CDE, Diabetes Care Center, University of Washington, 4225 Roosevelt Way NE, Suite 101, Box 354691, Seattle, WA 98105. Polycystic Ovarian Syndrome: Metformin or Thiazolidinediones for Cardiovascular Risk Reduction? Mary Moyer Janci, ARNP, CDE, BC-ADM, Rhea Coquia Smith, PharmD, and Peggy Soule Odegard, BS,
متن کاملthe study of practical and theoretical foundation of credit risk and its coverage
پس از بررسی هر کدام از فاکتورهای نوع صنعت, نوع ضمانت نامه, نرخ بهره , نرخ تورم, ریسک اعتباری کشورها, کارمزد, ریکاوری, gdp, پوشش و وثیقه بر ریسک اعتباری صندوق ضمانت صادرات ایران مشخص گردید که همه فاکتورها به استثنای ریسک اعتباری کشورها و کارمزد بقیه فاکتورها رابطه معناداری با ریسک اعتباری دارند در ضمن نرخ بهره , نرخ تورم, ریکاوری, و نوع صنعت و ریسک کشورها اثر عکس روی ریسک اعتباری داردو پوشش, وثی...
15 صفحه اولMDM2 and p53: a question of balance.
Since the initial discovery of mutations in the p53 (also known as TP53) gene in colorectal carcinoma, notable progress has been made in elucidating the role of p53 in the regulation of gene expression, cycle progression, and apoptosis (7). It is now recognized that p53 is induced in response to some types of DNA damage and that it is a key component of the physiologic checkpoint pathway that g...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Cardiology Reviews
سال: 2009
ISSN: 1573-403X
DOI: 10.2174/157340309788970333